ASQ Certified Biomedical Auditor (CBA) Practice Test

ASQ requires a minimum of 8 years of on-the-job experience in one or more areas of the Certified Biomedical Auditor Body of Knowledge. This must include at least 3 years in a decision-making position. A portion of this requirement can be waived with a degree from a technical, trade, or university program. For example, a diploma from a technical or trade school reduces the requirement to 7 years, an associate's degree to 6 years, a bachelor's degree to 4 years, and a master's or doctorate to 3 years. It is critical to review ASQ's official eligibility calculator for the most current and detailed breakdown.

While the Certified Quality Auditor (CQA) focuses on general quality management system auditing principles applicable across industries, the CBA is a specialized credential for the biomedical/medical device sector. The CBA exam delves deeply into industry-specific regulations such as the FDA Quality System Regulation (21 CFR Part 820), ISO 13485 for medical devices, ISO 14971 for risk management, and unique aspects like design controls, clinical evaluations, and vigilance reporting. The CBA's content is tailored to the unique regulatory, technical, and ethical challenges of auditing organizations that develop, manufacture, and distribute medical products.

The Design Controls section focuses on auditing the structured, iterative process of designing a medical device to ensure it meets user needs, intended uses, and regulatory requirements. Key audit points include design and development planning, design inputs, design outputs, design review, design verification, design validation, design transfer, and design changes. An auditor must assess whether the design history file (DHF) is maintained and traceable, ensuring that the design process is controlled and documented to mitigate risks and demonstrate that the resulting device is safe and effective for its intended purpose.

Supplier auditing is critical because the quality of finished medical devices is inherently dependent on the quality of supplied components, materials, and services (including contract manufacturing and sterilization). A Biomedical Auditor must evaluate a supplier's quality management system to ensure it is capable of consistently meeting specified requirements. This involves assessing the organization's supplier control procedures, including selection, evaluation, re-evaluation, and the management of supplier non-conformances. Effective supplier auditing mitigates supply chain risk, prevents defects, and is a key expectation of regulators like the FDA and under ISO 13485.

Risk management, per ISO 14971, is not a standalone activity but is integrated into all stages of the product lifecycle and quality system. A Biomedical Auditor must verify that risk management principles are applied to design controls, process validation, supplier management, corrective and preventive actions (CAPA), and post-market surveillance. The audit examines whether risks are systematically identified, analyzed, evaluated, controlled, and reviewed, and that the overall residual risk is acceptable. The output of risk management drives the audit focus, prioritizing high-risk processes and components for deeper scrutiny.